The global clinical trial landscape has changed significantly, with the Asia Pacific involved in more than a third of trials between 2017 and 2021.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more